| Title |
Host immunity following near infrared photoimmunotherapy is enhanced with PD-1 checkpoint blockade to eradicate established antigenic tumors
|
|---|---|
| Published in |
Cancer Immunology Research, March 2019
|
| DOI | 10.1158/2326-6066.cir-18-0546 |
| Pubmed ID | |
| Authors |
Tadanobu Nagaya, Jay Friedman, Yasuhiro Maruoka, Fusa Ogata, Shuhei Okuyama, Paul E Clavijo, Peter L Choyke, Clint Allen, Hisataka Kobayashi |
X Demographics
The data shown below were collected from the profiles of 10 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 2 | 20% |
| Mexico | 1 | 10% |
| Germany | 1 | 10% |
| Finland | 1 | 10% |
| Japan | 1 | 10% |
| China | 1 | 10% |
| United Kingdom | 1 | 10% |
| Unknown | 2 | 20% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 6 | 60% |
| Scientists | 3 | 30% |
| Science communicators (journalists, bloggers, editors) | 1 | 10% |
Mendeley readers
The data shown below were compiled from readership statistics for 70 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 70 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Ph. D. Student | 10 | 14% |
| Researcher | 7 | 10% |
| Student > Master | 7 | 10% |
| Student > Bachelor | 4 | 6% |
| Student > Doctoral Student | 4 | 6% |
| Other | 6 | 9% |
| Unknown | 32 | 46% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 11 | 16% |
| Pharmacology, Toxicology and Pharmaceutical Science | 8 | 11% |
| Immunology and Microbiology | 5 | 7% |
| Biochemistry, Genetics and Molecular Biology | 4 | 6% |
| Chemistry | 3 | 4% |
| Other | 6 | 9% |
| Unknown | 33 | 47% |
Attention Score in Context
This research output has an Altmetric Attention Score of 16. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 10 October 2023.
All research outputs
#2,342,913
of 25,608,265 outputs
Outputs from Cancer Immunology Research
#253
of 1,574 outputs
Outputs of similar age
#52,275
of 368,738 outputs
Outputs of similar age from Cancer Immunology Research
#11
of 85 outputs
Altmetric has tracked 25,608,265 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 90th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,574 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 13.0. This one has done well, scoring higher than 83% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 368,738 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 85% of its contemporaries.
We're also able to compare this research output to 85 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 88% of its contemporaries.